← Open Payments lookup

JOHN GENTRY: Open Payments

NPI 1932351061 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$571 in 32 payments from 15 companies in 2025. Trend: 2023 $845 · 2024 $273 · 2025 $571

Food & beverage: $571
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.5$94
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$85
Teva Pharmaceuticals USA, Inc.4$68
Otsuka America Pharmaceutical, Inc.3$52
Alkermes, Inc.2$50
Axsome Therapeutics, Inc.2$37
ABBVIE INC.2$34
Takeda Pharmaceuticals U.S.A., Inc.2$32
OWP Pharmaceuticals, Inc.1$22
Indivior Inc.1$20

Products named: FANAPT, CAPLYTA, AUSTEDO XR, REXULTI, ARISTADA, Auvelity, VRAYLAR, TRINTELLIX.

Industry payments across GA — which companies pay providers there.